EPHX2 and prostate neoplasm: Because sEH is both a marker for and a cause of inflammation and tumorigenesis (10, 11, 65), we first measured gene expression of Ephx2, the gene that encodes sEH, in bladder and prostate tumors in mice treated with ICIs.